Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Follicular × Psychotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anxiety Disorders 2 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Hospice 1 Hematopoietic and Lymphatic System Neoplasm 1 Depression 1 Breast Neoplasms 1

Interventions

Rituximab 130 Cyclophosphamide 113 Peripheral Blood Stem Cell Transplantation 59 fludarabine phosphate 55 Etoposide 47 Mycophenolic Acid 44 Radiotherapy 41 Filgrastim 41 Tacrolimus 40 Whole-Body Irradiation 36 Busulfan 34 Melphalan 33 Cyclosporine 30 Cytarabine 29 Methotrexate 28 sargramostim 27 Vincristine 27 Antilymphocyte Serum 27 Prednisone 26 obinutuzumab 22 Lenalidomide 22 Doxorubicin 22 Carmustine 21 Bortezomib 20 Methylprednisolone 19 fludarabine 17 Dexamethasone 17 Bendamustine Hydrochloride 17 ibritumomab tiuxetan 15 Cord Blood Stem Cell Transplantation 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06225232 2025-03-19

PSI_CUD

McMaster University

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡